JOPIC
Journal of Pulmonology and Intensive Care

The JoPIC is an independent-unbiased, peer-reviewed, and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, surgical techniques, differential diagnoses, editorial opinions, letters to the editor, and educational papers in pulmonology, thoracic surgery, occupational diseases, allergology, and intensive care medicine.

eISSN: 2980-0803
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
A case of early-stage lung cancer diagnosed concurrently with dasatinib-induced pleural effusion in a patient with chronic myeloid leukemia
Abstract
Advancements in cancer therapies have increased patient survival rates but have also brought about a higher risk of secondary malignancies. Dasatinib, a tyrosine kinase inhibitor commonly used in the treatment of chronic myeloid leukemia, is known to be associated with adverse effects such as pleural effusion. In this report, we present a case of a patient who developed pleural effusion during dasatinib therapy and was subsequently diagnosed with early-stage lung cancer upon further investigation. This case underscores the importance of a multidisciplinary approach in oncologic follow-up and highlights the need for vigilance regarding secondary primary malignancies.

Keywords : Secondary neoplasms, thoracic neoplasms, drug toxicity, diagnostic imaging, multidisciplinary approach

Download Article


1. Sasaki K, Strom SS, O’Brien S et al. Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials. Lancet Haematol. 2015;2(5):e186-193. doi:10.1016/S2352-3026(15)00048-4
2. Jain AG, Gesiotto Q, Ball S et al. Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML. Ann Hematol. 2024;103(6):1941-1945. doi:10. 1007/s00277-024-05760-6
3. Shah BK, Khanal A. Second primary malignancies in mantle cell lymphoma: a US population-based study. Anticancer Res. 2015;35(6):3437-3440.
4. Cheng F, Xu Q, Li Q, Cui Z, Li W, Zeng F. Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: characteristics, potential mechanisms, and clinical management strategies. Front Oncol. 2023;13:1113462. doi:10.3389/fonc.2023.1113462
5. Simard JL, Kircher SM, Didwania A, Goel MS. Screening for recurrence and secondary cancers. Med Clin North Am. 2017;101(6):1167-1180. doi: 10.1016/j.mcna.2017.06.010
6. Geng F, Liu M, Chen J et al. Clinical characteristics of second primary malignancies among first primary malignancy survivors: a single-center study, 2005-2020. Oncol Lett. 2022;25(1):24. doi:10.3892/ol.2022. 13610
7. Liu Y, Chu Y, Liu J et al. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis. Ann Med. 2023;55(2):2282652. doi:10.1080/07853890.2023.2282652
8. Bray F, Laversanne M, Sung H et al. A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 ;74(3):229-263. doi:10. 3322/caac.21834
9. Torrente M, Sousa PA, Franco F et al. Understanding prognosis and survival outcomes in patients with early-stage non-small-cell lung cancer. Clin Med (Lond). 2022;22(Suppl 4):38-40. doi:10.7861/clinmed. 22-4-s38
Article available in :
Volume 4, Issue 2, 2026
Page : 20-22
https://doi.org/10.51271/JOPIC-0079
Article Information
Received : 11 Haz 2025
Accepted : 11 Tem 2025
Published : 21 May 2026
Corresponding Author :

Maşide Arı: Department of Pulmonology, Ankara Atatürk Sanatorium Training and Research Hospital, Ankara, Turkiye

[email protected]
Citation : Arı M, Kurt B, Albayrak M. A case of early-stage lung cancer diagnosed concurrently with dasatinib-induced pleural effusion in a patient with chronic myeloid leukemia . J Pulmonol Intens Care. 2026;4(2):50-52. doi:10.51271/JOPIC-0079

Read: 98
Download : 63
Cited: 0
_Footer